Assembly Biosciences, Inc. Amortization of Debt Discount (Premium)
Assembly Biosciences, Inc. (ASMB) reported Amortization of Debt Discount (Premium) of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-05-14
- Assembly Biosciences, Inc. amortization of debt discount (premium) for the quarter ending 2014-03-31 was $0.00.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for the quarter ending 2013-09-30 was $0.00.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for the quarter ending 2013-06-30 was $0.00.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for the quarter ending 2013-03-31 was $0.00.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for fiscal 2011 was $302.33K, a 87.83% decline from fiscal 2010.
- Assembly Biosciences, Inc. amortization of debt discount (premium) for fiscal 2010 was $2.48M, a 3065.35% increase from fiscal 2009.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 69 month | Amortization of Debt Discount (Premium) 72 month | Amortization of Debt Discount (Premium) 75 month | Amortization of Debt Discount (Premium) 78 month | Amortization of Debt Discount (Premium) 81 month | Amortization of Debt Discount (Premium) 84 month | Amortization of Debt Discount (Premium) 87 month | Amortization of Debt Discount (Premium) 90 month | Amortization of Debt Discount (Premium) 93 month | Amortization of Debt Discount (Premium) 96 month | Amortization of Debt Discount (Premium) 99 month | Amortization of Debt Discount (Premium) 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $2.87M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 | $2.87M 10-K · filed 2014-03-31 | ||||||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $2.87M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $2.87M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $2.87M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $2.87M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-12 | $2.87M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $253.30K derived: sum of 4 quarters · filed 2013-08-09 | $2.87M 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $253.30K derived: sum of 3 quarters · filed 2013-05-10 | $277.81K derived: sum of 4 quarters · filed 2013-05-10 | $2.87M 10-Q · filed 2012-05-09 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $253.30K derived: sum of 2 quarters · filed 2013-03-18 | $277.81K derived: sum of 3 quarters · filed 2013-03-18 | $302.33K 10-K · filed 2013-03-18 | $2.87M 10-K · filed 2012-03-14 | |||||||||||
| 2011-09-30 | $253.30K 10-Q · filed 2012-11-13 | $277.81K derived: sum of 2 quarters · filed 2012-11-13 | $302.33K 10-Q · filed 2012-11-13 | $302.33K derived: sum of 4 quarters · filed 2013-03-18 | $2.87M 10-Q/A · filed 2011-11-18 | |||||||||||
| 2011-06-30 | $24.51K 10-Q · filed 2012-08-09 | $49.02K 10-Q · filed 2012-08-09 | $49.02K derived: sum of 3 quarters · filed 2013-03-18 | $629.24K derived: sum of 4 quarters · filed 2013-03-18 | $2.61M 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $24.51K 10-Q · filed 2012-05-09 | $24.51K derived: sum of 2 quarters · filed 2013-03-18 | $604.73K derived: sum of 3 quarters · filed 2013-03-18 | $1.39M derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $580.22K derived: sum of 2 quarters · filed 2013-03-18 | $1.37M derived: sum of 3 quarters · filed 2013-03-18 | $2.48M 10-K · filed 2013-03-18 | ||||||||||||
| 2010-09-30 | $580.22K 10-Q/A · filed 2011-11-18 | $1.37M derived: sum of 2 quarters · filed 2011-11-18 | $2.48M 10-Q/A · filed 2011-11-18 | |||||||||||||
| 2010-06-30 | $784.79K 10-Q · filed 2011-08-15 | $1.90M 10-Q · filed 2011-08-15 | ||||||||||||||
| 2009-12-31 | $78.50K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |